NorthWest Biotherapeutics Inc (NWBO)

[FrostyIsland3]

The MHRA does not reject a MAA without the CHM first issuing a CHM Letter to the new medicine’s sponsor. Linda Powers knows whether the CHM issued a CHM Letter or a 2nd RFI to NWBO regarding the DCVax-L MAA following the 11/27-28/2025 CHM meeting. The CTBVEAG 11/24/2025 meeting notes are clearly referring to DCVax-L. Those CTBVEAG notes are consistent with CHM issuing a 2nd RFI to NWBO shortly after 11/28/2025. In order to believe that the CHM acted on advice from the CTBVEAG by issuing a CHM Letter to NWBO, you have to conclude that Linda Powers has been engaging in a fraudulent scheme to mislead investors since late November 2025.

This would mean that her upbeat demeanor at the 12/29/2025 shareholders meeting was all an act to mislead shareholders into having confidence that the MAA is proceeding well. Second, all of the construction activity is similarly all part of a fraudulent scheme to mislead us. Third, the hiring of Dr. Jenkins is a carefully calibrated statement to mislead us into thinking that Dr. Jenkins was hired to exploit a pending approval of the DCVax-L MAA when the true purpose was for Dr. Jenkins to help with an appeal of a. CHM Letter. Linda Powers would know that doing all of this is going to result in civil liability for US securities fraud.